In a decisive stand for family values and parental rights, Polish President Andrzej Duda vetoed the controversial amendment to the Pharmaceutical Law related to “Morning-After Pill,” as announced by Małgorzata Paprocka, a distinguished minister in the President’s office. This bold action, motivated by the overwhelming outcry from concerned parents across the nation, signifies the administration’s unwavering dedication to preserving the sanctity of children’s healthcare and upholding the constitution’s healthcare standards.
Minister Paprocka conveyed that President Duda, guided by a deep sense of responsibility, heeded the substantial feedback from parents. “The President has made it clear: our children’s health and constitutional rights are paramount. He has shown his unwavering commitment to these principles by listening to the heartfelt concerns of Polish families,” she stated, elucidating on the President’s rationale behind the veto.
The veto ensures the continued regulated access to “Morning-After Pil,” specifically the drug EllaOne, which will remain prescription-based. This decision reinforces the government’s stance on keeping such sensitive healthcare decisions under professional medical supervision for those under 18, reflecting a profound respect for health protection and the authority of parents over their children’s healthcare choices.